Effects of Etretinate on Keratinocyte Proliferation and Secretion of Interleukin‐1α (IL‐1α) and IL‐8
Authors:
- 1 September 1994
- journal article
- research article
- Published by Wiley in The Journal of Dermatology
- Vol. 21 (9) , 633-638
Abstract
Etretinate has proven to be effective in the treatment of psoriasis. Since abnormal proliferation and cytokine secretion are well‐known features of psoriatic epidermis, we studied thein vitroeffects of etretinate on these two processes using human keratinocytes. Etretinate promoted proliferation of normal human keratinocytes (NHKs) grown in keratinocyte growth medium (KGM) but not in growth factor‐deficient keratinocyte basic medium (KBM). Moreover, etretinate partly overcame growth inhibition by PMA. Etretinate was shown to have an effect on either IL‐1α or IL‐8 secretion in unstimulated NHKs. In HSC‐1, a human squamous cell carcinoma cell line cultured in 20% FCS/DMEM, inhibited IL‐1α secretion and enhanced IL‐8 secretion. These results indicate that the effects of etretinate on keratinocyte proliferation and cytokine secretion may depend on cell type and culture conditions. Stimulation of NHKs with PMA significantly enhanced IL‐1α and IL‐8 secretion, and these effects were inhibited by etretinate. However, etretinate failed to inhibit rTNFα‐induced IL‐8 secretion, suggesting that etretinate regulation of NHK cytokine secretion may also depend on the stimulus. As treatment of keratinocytes or epidermis with PMA can induce psoriasis‐like changes, so might the experimental “anti‐PMA” activity of etretinate be related to its therapeutic benefit in the treatment of psoriasis.Keywords
This publication has 18 references indexed in Scilit:
- Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 alpha (IL-1α) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1)Journal of Dermatological Science, 1994
- The skin immune system and psoriasisClinical and Experimental Immunology, 1993
- Studies and perspectives of signal transduction in the skinExperimental Dermatology, 1992
- Transcription of the Human Loricrin Gene In Vitro Is Induced by Calcium and Cell Density and Suppressed by Retinoic AcidJournal of Investigative Dermatology, 1991
- Keratinocytes as initiators of inflammationThe Lancet, 1991
- Effect of topical retinoic acid on the interleukin Iα and β immunoreactive pool in normal human epidermisBritish Journal of Dermatology, 1990
- The Activated Keratinocyte: A Model for Inducible Cytokine Production by Non-Bone-Marrow-Derived Cells in Cutaneous Inflammatory and Immune ResponsesJournal of Investigative Dermatology, 1990
- Effects of Retinoids on Phorbol Ester-Stimulated Epidermal DNA Synthesis and Hyperplasia in Hairless Mice.Journal of Investigative Dermatology, 1989
- Retinoid Effect on Calcium, Phospholipid-Dependent Protein Kinase from Mouse SkinJournal of Investigative Dermatology, 1986
- Systemic treatment of psoriasis with an oral retinoic acid derivative (Ro 10-9359)British Journal of Dermatology, 1980